speb/financial-data huggingface dataset:
CRON.TO income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 736000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 700000.00
CRON.TO cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 104000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 36000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Income Tax Payable: 0.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 0.00
CRON.TO income_statement (annual, 2025-12-31) — Interest Income: 39963000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Interest Income: 9559000.00
CRON.TO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 39963000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 9559000.00
CRON.TO cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 0.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 0.00
CRON.TO balance_sheet (annual, 2025-12-31) — Inventory: 46750000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 46750000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 1093897000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 1093897000.00
CRON.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -76559000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 2782000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Investments And Advances: 7664000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 7664000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Land And Improvements: 7245000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 7245000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Loans Receivable: 0.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Loans Receivable: 0.00
CRON.TO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 1172000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 1172000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1172000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1172000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 50208000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 50208000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Minority Interest: 49062000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Minority Interest: 49062000.00
CRON.TO income_statement (annual, 2025-12-31) — Minority Interests: -6518000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Minority Interests: -1325000.00
CRON.TO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
CRON.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -9741000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -4270000.00
CRON.TO cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 28588000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 10418000.00
CRON.TO income_statement (annual, 2025-12-31) — Net Income: -9447000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Net Income: -1816000.00
CRON.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -9447000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -1816000.00
CRON.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -2929000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -491000.00
CRON.TO income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 0.00
CRON.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -9447000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -1816000.00
CRON.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -9447000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1816000.00
CRON.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -2929000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -491000.00
CRON.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -2929000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -491000.00
CRON.TO cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -339000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -135000.00
CRON.TO income_statement (annual, 2025-12-31) — Net Interest Income: 39963000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: 9559000.00
CRON.TO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -45107000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 0.00
CRON.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 39963000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 9559000.00
CRON.TO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -10164000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -3153000.00
CRON.TO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -5396000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 5056000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Net PPE: 147287000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 147287000.00
CRON.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -25717000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -2139000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 1018529000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 1018529000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 1888000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 1888000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 4089000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 4089000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 1888000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 1888000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 4089000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 4089000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Non Current Note Receivables: 20847000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Non Current Note Receivables: 20847000.00
CRON.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: 32079000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 12806000.00
CRON.TO income_statement (annual, 2025-12-31) — Normalized Income: 22296250.00
CRON.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 11398950.00
CRON.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 25866000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 11835000.00
CRON.TO cash_flow (annual, 2025-12-31) — Operating Gains Losses: 34566000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 14346000.00
CRON.TO income_statement (annual, 2025-12-31) — Operating Income: -19497000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Operating Income: -6398000.00
CRON.TO income_statement (annual, 2025-12-31) — Operating Revenue: 193363000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 58385000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 381592969.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 381592969.00
CRON.TO balance_sheet (annual, 2025-12-31) — Other Current Assets: 8344000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 8344000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -16842000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -16842000.00
CRON.TO income_statement (annual, 2025-12-31) — Other Gand A: 41999000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Other Gand A: 12900000.00
CRON.TO income_statement (annual, 2025-12-31) — Other Income Expense: -37586000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: -15547000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 8890000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 8890000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Other Investments: 7664000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Other Investments: 7664000.00
CRON.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 1767000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -1117000.00
CRON.TO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -241000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 0.00
CRON.TO balance_sheet (annual, 2025-12-31) — Other Properties: 1422000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 1422000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Other Receivables: 14445000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 14445000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 40000000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 40000000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Payables: 27742000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Payables: 27742000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 47850000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 47850000.00
CRON.TO income_statement (annual, 2025-12-31) — Pretax Income: -17120000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Pretax Income: -12386000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Properties: 0.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CRON.TO income_statement (annual, 2025-12-31) — Provision For Doubtful Accounts: 4875000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Provision For Doubtful Accounts: 104000.00
CRON.TO cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 4859000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 93000.00
CRON.TO cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -339000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -135000.00
CRON.TO cash_flow (annual, 2025-12-31) — Purchase Of Investment: -45107000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 0.00
CRON.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -25717000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -2139000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Raw Materials: 8908000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Raw Materials: 8908000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Receivables: 57198000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 57198000.00
CRON.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 71716000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 25087000.00
CRON.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 14231000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 3657000.00
CRON.TO cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -9741000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -4270000.00
CRON.TO income_statement (annual, 2025-12-31) — Research And Development: 4449000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Research And Development: 1382000.00
CRON.TO income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 2037000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 502000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: 447756000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 447756000.00
CRON.TO income_statement (annual, 2025-12-31) — Salaries And Wages: 7050000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Salaries And Wages: 1248000.00
CRON.TO cash_flow (annual, 2025-12-31) — Sale Of Business: 0.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
CRON.TO cash_flow (annual, 2025-12-31) — Sale Of Investment: 0.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 0.00
CRON.TO income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 21764000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 6551000.00
CRON.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 70813000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 20699000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Share Issued: 381592969.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 381592969.00
CRON.TO income_statement (annual, 2025-12-31) — Special Income Charges: -8305000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Special Income Charges: -1202000.00
CRON.TO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 7050000.00
CRON.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 1248000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 1093897000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1093897000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 1018529000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 1018529000.00
CRON.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -5601750.00
CRON.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -2332050.00
CRON.TO income_statement (annual, 2025-12-31) — Tax Provision: -14191000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Tax Provision: -11895000.00
CRON.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.15
CRON.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
CRON.TO balance_sheet (annual, 2025-12-31) — Total Assets: 1197140000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 1197140000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 1093897000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1093897000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Total Debt: 1509000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 1509000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 1142959000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1142959000.00
CRON.TO income_statement (annual, 2025-12-31) — Total Expenses: 166084000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 50929000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 54181000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 54181000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 253054000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 253054000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 5994000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 5994000.00
CRON.TO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -17395000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -7496000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Total Tax Payable: 16102000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 16102000.00
CRON.TO income_statement (annual, 2025-12-31) — Total Unusual Items: -37345000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: -15547000.00
CRON.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -37345000.00
CRON.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -15547000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 0.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 0.00
CRON.TO balance_sheet (annual, 2025-12-31) — Work In Process: 25830000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Work In Process: 25830000.00
CRON.TO balance_sheet (annual, 2025-12-31) — Working Capital: 895899000.00
CRON.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 895899000.00
CRON.TO income_statement (annual, 2025-12-31) — Write Off: 0.00
CRON.TO income_statement (quarterly, 2025-12-31) — Write Off: 0.00
CRON.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 20608000.00
CRON.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 45210000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 10281000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 32962000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Accrued Interest Receivable: 5734000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -152164000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 343800000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 0.04
CRON.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 791794000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 235368000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -1971000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 1311000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 647040000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 821856000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 821856000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -18268000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 38029000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 10898000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -1206000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -5139000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: 1387000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Change In Inventory: -2039000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Change In Payable: 181000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -4958000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 3310000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: 3963000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: 1387000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 276000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 879000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: 30659000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 647040000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1073662000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -16730000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 363000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 26057000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 30601000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 927876000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 169000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 169000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 42420000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 3727000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 425000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 3727000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 425000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 343800000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.04
CRON.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 13752000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Non Current: 749000.00
CRON.TO income_statement (quarterly, 2026-03-31) — EBIT: -1455000.00
CRON.TO income_statement (quarterly, 2026-03-31) — EBITDA: 2272000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -597000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 821856000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Excise Taxes: 13755000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -18268000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Finished Goods: 13578000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 8927000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 2484000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 11215000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -33918000.00
CRON.TO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 13049000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Goodwill: 65436000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 73985000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 295569000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 19153000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 8000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 1369000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Interest Income: 8853000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 8853000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 0.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 48676000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1073662000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 38029000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 5199000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 7183000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Loans Receivable: 128000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 1142000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1142000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 51352000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Minority Interest: 50152000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Minority Interests: -1959000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -16730000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -13699000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Net Income: 13752000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 13752000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 15711000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 13752000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 13752000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 15711000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 15711000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -96000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: 8853000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 40000000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 8853000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -1538000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 143405000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -1875000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 999677000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 841000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 3984000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 841000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 3984000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Non Current Note Receivables: 20803000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -8459000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Normalized Income: 4457400.46
CRON.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 10898000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -11215000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Operating Income: -1455000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 58965000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 376258707.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 4974000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -33918000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Other Gand A: 11736000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: 10741000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 8549000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Other Investments: 5199000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 979000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 10000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Other Properties: 1303000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Other Receivables: 13546000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 0.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Payables: 11650000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 42251000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Pretax Income: 18139000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
CRON.TO income_statement (quarterly, 2026-03-31) — Provision For Doubtful Accounts: 106000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 107000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -96000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: 0.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -1875000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Raw Materials: 9266000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 52370000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 22755000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 3727000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -16730000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Research And Development: 1413000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 484000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 460540000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Salaries And Wages: 1313000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 40000000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 5615000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 18664000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 376258707.00
CRON.TO income_statement (quarterly, 2026-03-31) — Special Income Charges: -484000.00
CRON.TO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 1313000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1073662000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 999677000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 1436400.46
CRON.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 2428000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.13
CRON.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 1172109000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1073662000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 1311000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1123814000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 46665000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 48295000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 244233000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 5875000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -1833000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 1369000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: 10731000.00
CRON.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 10731000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 0.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Work In Process: 25832000.00
CRON.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: 885456000.00
CROS.PA income_statement (annual, 2021-12-31) — Basic Average Shares: 10632960.00
CROS.PA income_statement (annual, 2021-12-31) — Basic EPS: 0.74
CROS.PA cash_flow (annual, 2021-12-31) — Cash Dividends Paid: -4041000.00
CROS.PA income_statement (annual, 2021-12-31) — Diluted Average Shares: 10632960.00
CROS.PA income_statement (annual, 2021-12-31) — Diluted EPS: 0.74
CROS.PA balance_sheet (annual, 2021-12-31) — Financial Assets: 0.00
CROS.PA balance_sheet (annual, 2021-12-31) — Inventory: 0.00
CROS.PA balance_sheet (annual, 2021-12-31) — Long Term Provisions: 273000.00
CROS.PA balance_sheet (annual, 2021-12-31) — Net Debt: 4112000.00
CROS.PA cash_flow (annual, 2021-12-31) — Net Other Investing Changes: -93000.00
CROS.PA balance_sheet (annual, 2021-12-31) — Retained Earnings: 7828000.00
CROS.PA income_statement (annual, 2021-12-31) — Selling And Marketing Expense: 0.00
CROS.PA income_statement (annual, 2021-12-31) — Total Other Finance Cost: 13000.00
CROS.PA income_statement (annual, 2022-12-31) — +Operating Expense: 203000.00
CROS.PA income_statement (annual, 2022-12-31) — +Total Revenue: 1114000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Accounts Payable: 209000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Accounts Receivable: 12000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 19913000.00
CROS.PA income_statement (annual, 2022-12-31) — Basic Average Shares: 10632960.00
CROS.PA income_statement (annual, 2022-12-31) — Basic EPS: 0.57
CROS.PA cash_flow (annual, 2022-12-31) — Beginning Cash Position: 2471000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Capital Stock: 10633000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1443000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 1443000.00
CROS.PA cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -1063000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Cash Financial: 1443000.00
CROS.PA cash_flow (annual, 2022-12-31) — Change In Working Capital: 110000.00
CROS.PA cash_flow (annual, 2022-12-31) — Changes In Cash: -1028000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Common Stock: 10633000.00
CROS.PA cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -1063000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Common Stock Equity: 82231000.00
CROS.PA income_statement (annual, 2022-12-31) — Cost Of Revenue: 295000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Current Assets: 1723000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Current Debt: 677000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 677000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Current Liabilities: 1095000.00
CROS.PA cash_flow (annual, 2022-12-31) — Deferred Tax: 2801000.00
CROS.PA cash_flow (annual, 2022-12-31) — Depreciation: 7000.00
CROS.PA cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 7000.00
CROS.PA income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 7000.00
CROS.PA income_statement (annual, 2022-12-31) — Depreciation Income Statement: 7000.00
CROS.PA income_statement (annual, 2022-12-31) — Diluted Average Shares: 10632960.00
CROS.PA income_statement (annual, 2022-12-31) — Diluted EPS: 0.57
CROS.PA income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 6034000.00
CROS.PA income_statement (annual, 2022-12-31) — EBIT: 345000.00
CROS.PA income_statement (annual, 2022-12-31) — EBITDA: 352000.00
CROS.PA cash_flow (annual, 2022-12-31) — End Cash Position: 1443000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Financial Assets: 0.00
CROS.PA cash_flow (annual, 2022-12-31) — Financing Cash Flow: -2598000.00
CROS.PA cash_flow (annual, 2022-12-31) — Free Cash Flow: -477000.00
CROS.PA cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 271000.00
CROS.PA income_statement (annual, 2022-12-31) — Gross Profit: 819000.00
CROS.PA income_statement (annual, 2022-12-31) — Interest Expense: 106000.00
CROS.PA income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 106000.00
CROS.PA income_statement (annual, 2022-12-31) — Interest Income: 0.00
CROS.PA income_statement (annual, 2022-12-31) — Interest Income Non Operating: 0.00
CROS.PA cash_flow (annual, 2022-12-31) — Interest Paid Cff: -105000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Inventory: 0.00
CROS.PA balance_sheet (annual, 2022-12-31) — Invested Capital: 87387000.00
CROS.PA cash_flow (annual, 2022-12-31) — Investing Cash Flow: 2047000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Investment Properties: 12400000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 90307000.00
CROS.PA cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
CROS.PA balance_sheet (annual, 2022-12-31) — Long Term Debt: 4479000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 4479000.00
CROS.PA cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
CROS.PA cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -1446000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 90307000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Long Term Provisions: 273000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Minority Interest: 0.00
CROS.PA income_statement (annual, 2022-12-31) — Minority Interests: 0.00
CROS.PA balance_sheet (annual, 2022-12-31) — Net Debt: 3713000.00
CROS.PA income_statement (annual, 2022-12-31) — Net Income: 6034000.00
CROS.PA income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 6034000.00
CROS.PA income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 6034000.00
CROS.PA income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 6034000.00
CROS.PA income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 6034000.00
CROS.PA cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 6034000.00
CROS.PA income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 6034000.00
CROS.PA income_statement (annual, 2022-12-31) — Net Interest Income: -106000.00
CROS.PA cash_flow (annual, 2022-12-31) — Net Investment Properties Purchase And Sale: 2047000.00
CROS.PA cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -1446000.00
CROS.PA cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -1446000.00
CROS.PA income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -106000.00
CROS.PA cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 16000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Net PPE: 7000.00
CROS.PA cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 0.00
CROS.PA balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 82231000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 0.00
CROS.PA balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 15621000.00
CROS.PA income_statement (annual, 2022-12-31) — Normalized EBITDA: 352000.00
CROS.PA income_statement (annual, 2022-12-31) — Normalized Income: 6034000.00
CROS.PA cash_flow (annual, 2022-12-31) — Operating Cash Flow: -477000.00
CROS.PA income_statement (annual, 2022-12-31) — Operating Income: 616000.00
CROS.PA income_statement (annual, 2022-12-31) — Operating Revenue: 1114000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 10632960.00
CROS.PA balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 50000.00
CROS.PA cash_flow (annual, 2022-12-31) — Other Non Cash Items: 108000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 1000.00
CROS.PA income_statement (annual, 2022-12-31) — Other Operating Expenses: 205000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Other Payable: 70000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Other Receivables: 66000.00
CROS.PA income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
CROS.PA balance_sheet (annual, 2022-12-31) — Payables: 352000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Prepaid Assets: 8000.00
CROS.PA income_statement (annual, 2022-12-31) — Pretax Income: 239000.00
CROS.PA cash_flow (annual, 2022-12-31) — Purchase Of Investment Properties: -53000.00
CROS.PA income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 295000.00
CROS.PA income_statement (annual, 2022-12-31) — Reconciled Depreciation: 7000.00
CROS.PA income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 243000.00
CROS.PA cash_flow (annual, 2022-12-31) — Repayment Of Debt: -1446000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Retained Earnings: 6034000.00
CROS.PA cash_flow (annual, 2022-12-31) — Sale Of Investment Properties: 2100000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Share Issued: 10632960.00
CROS.PA balance_sheet (annual, 2022-12-31) — Stockholders Equity: 82231000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Tangible Book Value: 82231000.00
CROS.PA income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CROS.PA income_statement (annual, 2022-12-31) — Tax Provision: 2801000.00
CROS.PA income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.25
CROS.PA balance_sheet (annual, 2022-12-31) — Taxes Receivable: 194000.00
CROS.PA cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -1212000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Total Assets: 104437000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Total Capitalization: 86710000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Total Debt: 5156000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 82231000.00
CROS.PA income_statement (annual, 2022-12-31) — Total Expenses: 498000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 22206000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 102714000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 21111000.00
CROS.PA income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 616000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Total Tax Payable: 73000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Tradeand Other Payables Non Current: 1010000.00
CROS.PA balance_sheet (annual, 2022-12-31) — Working Capital: 628000.00
CROS.PA income_statement (annual, 2023-12-31) — +Operating Expense: 46000.00
CROS.PA income_statement (annual, 2023-12-31) — +Total Revenue: 1004000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Accounts Payable: 319000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Accounts Receivable: 51000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 19913000.00
CROS.PA income_statement (annual, 2023-12-31) — Basic Average Shares: 10632960.00
CROS.PA income_statement (annual, 2023-12-31) — Basic EPS: -0.17
CROS.PA cash_flow (annual, 2023-12-31) — Beginning Cash Position: 1443000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Capital Stock: 10633000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 72000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 72000.00
CROS.PA cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -1170000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Cash Equivalents: 0.00
CROS.PA balance_sheet (annual, 2023-12-31) — Cash Financial: 72000.00
CROS.PA cash_flow (annual, 2023-12-31) — Change In Working Capital: -17000.00
CROS.PA cash_flow (annual, 2023-12-31) — Changes In Cash: -1371000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Common Stock: 10633000.00
CROS.PA cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -1170000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Common Stock Equity: 79250000.00
CROS.PA income_statement (annual, 2023-12-31) — Cost Of Revenue: 281000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Current Assets: 1926000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Current Debt: 600000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 600000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Current Liabilities: 1272000.00
CROS.PA cash_flow (annual, 2023-12-31) — Deferred Tax: -971000.00
CROS.PA cash_flow (annual, 2023-12-31) — Depreciation: -264000.00
CROS.PA cash_flow (annual, 2023-12-31) — Depreciation And Amortization: -264000.00
CROS.PA income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: -264000.00
CROS.PA income_statement (annual, 2023-12-31) — Depreciation Income Statement: -264000.00
CROS.PA income_statement (annual, 2023-12-31) — Diluted Average Shares: 10632960.00
CROS.PA income_statement (annual, 2023-12-31) — Diluted EPS: -0.17
CROS.PA income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -1791000.00
CROS.PA cash_flow (annual, 2023-12-31) — Dividends Received Cfi: 710000.00
CROS.PA income_statement (annual, 2023-12-31) — EBIT: 1585000.00
CROS.PA income_statement (annual, 2023-12-31) — EBITDA: 1321000.00
CROS.PA cash_flow (annual, 2023-12-31) — End Cash Position: 72000.00
CROS.PA cash_flow (annual, 2023-12-31) — Financing Cash Flow: -1834000.00
CROS.PA cash_flow (annual, 2023-12-31) — Free Cash Flow: 354000.00
CROS.PA cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -907000.00
CROS.PA income_statement (annual, 2023-12-31) — Gross Profit: 723000.00
CROS.PA income_statement (annual, 2023-12-31) — Interest Expense: 84000.00
CROS.PA income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 84000.00
CROS.PA income_statement (annual, 2023-12-31) — Interest Income: 0.00
CROS.PA income_statement (annual, 2023-12-31) — Interest Income Non Operating: 0.00
CROS.PA cash_flow (annual, 2023-12-31) — Interest Paid Cff: -84000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Invested Capital: 83617000.00
CROS.PA cash_flow (annual, 2023-12-31) — Investing Cash Flow: 109000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Investment Properties: 12500000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 85309000.00
CROS.PA cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
CROS.PA balance_sheet (annual, 2023-12-31) — Long Term Debt: 3767000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 3767000.00
CROS.PA cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
CROS.PA cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -588000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 85309000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Minority Interest: 0.00
CROS.PA income_statement (annual, 2023-12-31) — Minority Interests: 0.00
CROS.PA balance_sheet (annual, 2023-12-31) — Net Debt: 4295000.00
CROS.PA income_statement (annual, 2023-12-31) — Net Income: -1791000.00
CROS.PA income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -1791000.00
CROS.PA income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -1791000.00
CROS.PA income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -1791000.00
CROS.PA income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -1791000.00
CROS.PA cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -1791000.00
CROS.PA income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -1791000.00
CROS.PA income_statement (annual, 2023-12-31) — Net Interest Income: -84000.00
CROS.PA cash_flow (annual, 2023-12-31) — Net Investment Properties Purchase And Sale: -602000.00
CROS.PA cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -588000.00
CROS.PA cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -588000.00
CROS.PA income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -84000.00
CROS.PA cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 8000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Net PPE: 0.00
CROS.PA cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 1000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 79250000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 0.00
CROS.PA balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 14640000.00
CROS.PA income_statement (annual, 2023-12-31) — Normalized EBITDA: 1321000.00
CROS.PA income_statement (annual, 2023-12-31) — Normalized Income: -1791000.00
CROS.PA cash_flow (annual, 2023-12-31) — Operating Cash Flow: 354000.00
CROS.PA income_statement (annual, 2023-12-31) — Operating Income: 677000.00
CROS.PA income_statement (annual, 2023-12-31) — Operating Revenue: 1004000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 10632960.00
CROS.PA balance_sheet (annual, 2023-12-31) — Other Current Assets: 1000.00
CROS.PA balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 55000.00
CROS.PA cash_flow (annual, 2023-12-31) — Other Non Cash Items: 84000.00